The tariff classification of Letrozole (CAS-112809-51-5) in bulk form, from India
Issued August 21, 2009 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2933.99.7500
Headings: 2933
Product description
The subject product, Letrozole, is a non-steroidal aromatase inhibitor. It is indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
CBP rationale
The applicable subheading for the Letrozole in bulk form will be 2933.99.7500, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Other: Other: Aromatic or modified aromatic: Other: Drugs: Other.
Full text
N072175 August 21, 2009 CLA-2-29:OT:RR:E:NC:N2:238 CATEGORY: Classification TARIFF NO.: 2933.99.7500 Ms. Wendy Zamor Matrix Laboratories Inc. 76 South Orange Ave., Suite 301 South Orange, NJ 07079 RE: The tariff classification of Letrozole (CAS-112809-51-5) in bulk form, from India Dear Ms. Zamor: In your letter dated August 13, 2009, you requested a tariff classification ruling. The subject product, Letrozole, is a non-steroidal aromatase inhibitor. It is indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer. The applicable subheading for the Letrozole in bulk form will be 2933.99.7500, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Other: Other: Aromatic or modified aromatic: Other: Drugs: Other.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at (646) 733-3033. Sincerely, Robert B. Swierupski Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Selumetinib Sulfate (CAS No. 943332-08-9) in bulk powder form, from Taiwan
The tariff classification of Bendamustine Hydrochloride (CAS No. 3543-75-7) in bulk powder form, from India
The tariff classification of Selumetinib Sulfate (CAS No. 943332-08-9) in bulk crystal form, from Taiwan
The tariff classification of Finerenone (CAS No. 1050477-31-0) in bulk form and Kerendia® Tablets in dosage form, from Germany
The tariff classification of Bortezomib (CAS 179324-69-7), imported in bulk powder form, from Taiwan
The tariff classification of Bendamustine Hydrochloride, imported in bulk form, from India
The tariff classification of Tolvaptan (CAS-150683-30-0) in bulk powder form, from India
The tariff classification of Deferasirox (CAS-201530-41-8) in bulk form
The tariff classification of Conivaptan Hydrochloride (CAS-168626-94-6) in bulk form, from Japan
The tariff classification of Bendamustine Hydrochloride (CAS-3543-75-7) in bulk from India
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →